Doctors Without Borders Calls Brazil’s Bluff on AIDS Patent

International medical aid agency Médecins Sans Frontières (Doctors Without Borders, MSF) criticized the Brazilian government for failing to “keep its pledge” to break antiretroviral drug patents to produce generic versions of the medicines.

Brazil in March threatened to break the patents on four antiretrovirals by April 4 if the drug manufacturers did not agree to allow the country to produce generic equivalents or buy them at discounted prices, but it has not done so, according to news agencies.


The Brazilian government asked U.S. drug companies Merck, Gilead and Abbott Laboratories to grant the government voluntary licensing to produce generic versions of four drugs produced by the companies and used in Brazil’s National STD/AIDS Program.


The drugs in question include Merck’s Efavirenz, Abbott’s Lopinavir and Ritonavir and Gilead’s Tenofovir.


Brazil’s national AIDS program, which is considered to be one of the most progressive in the world, already manufactures and distributes generic versions of antiretrovirals, providing them at no cost to all HIV-positive people in the country.


The program ignores all patents issued before 1997, when Brazil signed an intellectual property law in order to join the World Trade Organization.


The government over the past three years repeatedly has said it might break patent laws in order to negotiate price reductions with pharmaceutical companies.


“The lack of action on the part of Brazilian authorities is incomprehensible. On the international level, Brazil has publicly defended using the flexibilities included in the World Trade Organization’s TRIPS agreement.


“But when it comes time to transforming this bold posture into acts that benefit the Brazilian population, the government resembles a toothless tiger,” MSF said in a statement, which was signed by 107 other nongovernmental organizations.


A Ministry of Health spokesperson said that breaking a patent is a “delicate process” and the country does not want the pharmaceutical companies to stop supplying the drugs before Brazil can produce generic equivalents, according to the Associated Press.


Supplying the four brand-name antiretrovirals would cost Brazil US$ 169 million – or 67% of the government’s budget for imported AIDS medications – this year, according to health ministry figures.


The Henry J. Kaiser Family Foundation
www.kaisernetwork.org

Tags:

You May Also Like

Brazil: ‘Our Nuclear Program is Pacific and Strategic’

Brazil’s Minister of Science and Technology, Eduardo Campos, said today that the Brazilian government ...

African Authorities in Brazil Learn How Zero Hunger Works

A delegation of government officials from South Africa, Nigeria, Ghana, Mozambique, Guinea-Bissau, and Zambia ...

Brazil: 8 Ministers Leave Lula’s Cabinet to Run for Office

Brazilian President Luiz Inácio Lula da Silva has accepted the resignations of eight of ...

Brazil Says FARC Guerrillas Have Base in Brazilian Territory

According to secret Federal Police reports, extracts of which were published Sunday by daily ...

Brazilian Expatriates Are a Main Reason for Less Poverty in Brazil

Despite some progress over the past two years, poverty in Latinamerica and the Caribbean ...

U.S. High Interests Rates Weigh on Brazil Stocks

Latin America continued to suffer from ongoing global inflation fears and concerns that U.S. ...

Brazil-Venezuela Joint Venture Will Make Brazilian Northeast Self-Sufficient in Oil

The construction project for an oil refinery in Industrial and Port Complex of Suape, ...

Brazil Threatens Severe Punishment to Anyone Growing GM Corn

The prodution of genetically modified (GM) corn (milho transgênico – transgenic corn) is strictly ...

Afrobrazilianists: Such Arrogance!

Brazilian progressive blacks are doing what they can to allow us to reach the ...

Brazilians Are the Aedes Aegypti of Brazil

The dengue fever epidemic currently affecting several Brazilian cities, especially Rio de Janeiro, is ...